Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT 201 in Essential Tremor of the Upper Limb
NCT04766723Phase 2Completed
- Sponsor
- Merz
- Start
- Feb 2021
- Primary completion
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of incobotulinumtoxinA in essential tremor (ET), sponsored by Merz. Started Feb 2021; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT04766723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766723.